Nanotechnology Now - News Story: "Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?"

Home > News > Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

September 13th, 2005

Can Medical Nanotechnology Shorten Clinical Trials and Regulatory Pathways?

Abstract:
Nanotechnology is poised to enable advances that could be utilized to shave time and expense from multiple stages of the drug discovery and development efforts.

Source:
nano.cancer.gov

Bookmark:

Related Links

Ohio State University

National Cancer Institute

Related News Press

Possible Futures

European roadmap for graphene science and technology published February 25th, 2015

Quantum research past, present and future for discussion at AAAS February 16th, 2015

World’s first compact rotary 3D printer-cum-scanner unveiled at AAAS by NTU Singapore start-up: With production funded by crowdsourcing, the first unit will be delivered to the United States in March February 16th, 2015

Nanotechnology Electric Vehicle (EV) Market Analysis Report 2015: According to Radiant Insights, Inc February 13th, 2015

Nanomedicine

Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015

Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015

New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs March 2nd, 2015

New Hopes for Treatment of Intestine Cancer by Edible Nanodrug March 2nd, 2015